SCHEMBL371463

SCHEMBL371463

OCCCCC1=CCC=CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL379058 0.94
SCHEMBL2347801 0.82
SCHEMBL5489483 0.80 CA2 (0.35)
SCHEMBL6151243 0.80 CA2 (0.35)
SCHEMBL2348604 0.80 CA2 (0.35)
SCHEMBL2357992 0.79 HTR2A (0.35)
SCHEMBL17611074 0.78
SCHEMBL2347948 0.74
SCHEMBL7494175 0.73
SCHEMBL3672419 0.71 LMNA (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108250250-B Complex containing 1,1, 1-triphenyl-N- (1- (pyridine-2-) methylene) methylamine, preparation method and application 曲阜师范大学 2020-05-26 CN disclosed
US-20130172408-A1 Medicaments Based on Dinuclear Arene Ruthenium Complexes Comprising Bridging Thiolato, Selenolato or Alkoxo Ligands UNIVERSITE DE NEUCHATEL (CH) 2013-07-04 US disclosed
EP-2595622-A1 MEDICAMENTS BASED ON DINUCLEAR ARENE RUTHENIUM COMPLEXES COMPRISING BRIDGING THIOLATO, SELENOLATO OR ALKOXO LIGANDS Université de Neuchâtel (CH) 2013-05-29 EP disclosed
WO-2012010616-A1 MEDICAMENTS BASED ON DINUCLEAR ARENE RUTHENIUM COMPLEXES COMPRISING BRIDGING THIOLATO, SELENOLATO OR ALKOXO LIGANDS UNIVERSITÉ DE NEUCHÂTEL (CH) 2012-01-26 WO disclosed
EP-2409697-A1 Medicaments Based on Dinuclear Ruthenium, Osmium and Iron Complexes Comprising Triply Bridging Thiolato, Selenolato, Alkoxo and/or Amido Ligands Université de Neuchâtel (CH) 2012-01-25 EP disclosed